Common use of Initial Cure Period Clause in Contracts

Initial Cure Period. If Agilent becomes aware that Keysight or any of its Affiliates is not complying with any Trademark Usage Guidelines, Agilent shall notify Keysight in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Keysight shall then have forty-five (45) calendar days after receipt of such notice (“Guideline Initial Cure Period”) to correct such noncompliance or submit to Agilent a written plan to correct such noncompliance, which written plan shall be reasonably acceptable to Agilent, unless Agilent previously affirmatively concurs in writing, in its sole discretion, that Keysight or its Affiliate is in compliance. If Agilent or Keysight becomes aware that an Authorized Dealer is not complying with any Trademark Usage Guidelines, Keysight (but not Agilent) shall promptly notify such Authorized Dealer in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Such Authorized Dealer shall then have the Guideline Initial Cure Period to correct such noncompliance or submit to Keysight a written plan to correct such noncompliance, which written plan shall be reasonably acceptable to Keysight and Agilent.

Initial Cure Period. If Agilent Seller becomes aware that Keysight Purchaser or any of its Affiliates Subsidiary is not complying with any Trademark Usage Guidelines, Agilent Seller shall notify Keysight Purchaser in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Keysight Purchaser shall then have forty-five thirty (4530) calendar days after receipt of such notice (“Guideline Initial Cure Period”) to correct such noncompliance or submit to Agilent Seller a written plan to correct such noncompliance, which written plan shall be is reasonably acceptable to AgilentSeller, unless Agilent Seller previously affirmatively concurs in writing, in its sole discretion, that Keysight Purchaser or its Affiliate Subsidiary is not in compliancenoncompliance. If Agilent Seller or Keysight Purchaser becomes aware that an Authorized Dealer is not complying with any Trademark Usage Guidelines, Keysight Purchaser (but not AgilentSeller) shall promptly notify such Authorized Dealer in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Such Authorized Dealer shall then have the Guideline Initial Cure Period to correct such noncompliance or submit to Keysight Purchaser a written plan to correct such noncompliance, which written plan shall be is reasonably acceptable to Keysight Purchaser and AgilentSeller.

Initial Cure Period. If Agilent Seller becomes aware that Keysight Purchaser or any of its Affiliates Subsidiary is not complying with any Trademark Usage Guidelines, Agilent Seller shall notify Keysight Purchaser in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Keysight Purchaser shall then have forty-five thirty (4530) calendar days after receipt of such notice (“Guideline Initial Cure Period”) to correct such noncompliance or submit to Agilent Seller a written plan to correct such noncompliance, which written plan shall be is reasonably acceptable to AgilentSeller, unless Agilent Seller previously affirmatively concurs in writing, in its sole discretion, that Keysight Purchaser or its Affiliate Subsidiary is not in compliancenoncompliance. If Agilent Seller or Keysight Purchaser becomes aware that an Authorized Dealer is not complying with any applicable Trademark Usage Guidelines, Keysight Purchaser (but not AgilentSeller) shall promptly notify such Authorized Dealer in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Such Authorized Dealer shall then have the Guideline Initial Cure Period to correct such noncompliance or submit to Keysight Purchaser a written plan to correct such noncompliance, which written plan shall be is reasonably acceptable to Keysight Purchaser and AgilentSeller.

Initial Cure Period. If Agilent Seller becomes aware that Keysight Purchaser or any of its Affiliates Subsidiary is not complying with any Trademark Usage Guidelines, Agilent Seller shall notify Keysight Purchaser in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Keysight Purchaser shall then have forty-five thirty (4530) calendar days after receipt of such notice (“"Guideline Initial Cure Period”") to correct such noncompliance or submit to Agilent Seller a written plan to correct such noncompliance, which written plan shall be is reasonably acceptable to AgilentSeller, unless Agilent Seller previously affirmatively concurs in writing, in its sole discretion, that Keysight Purchaser or its Affiliate Subsidiary is not in compliancenoncompliance. If Agilent Seller or Keysight Purchaser becomes aware that an Authorized Dealer is not complying with any Trademark Usage Guidelines, Keysight Purchaser (but not AgilentSeller) shall promptly notify such Authorized Dealer in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Such Authorized Dealer shall then have the Guideline Initial Cure Period to correct such noncompliance or submit to Keysight Purchaser a written plan to correct such noncompliance, which written plan shall be is reasonably acceptable to Keysight Purchaser and AgilentSeller.

Initial Cure Period. If Agilent Seller becomes aware that Keysight Purchaser or any of its Affiliates Subsidiary is not complying with any the Seller Trademark Usage Guidelines, Agilent Seller shall notify Keysight Purchaser in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Keysight Purchaser shall then have forty-five thirty (4530) calendar days after receipt of such notice (“Guideline Initial Cure Period”) to correct such noncompliance or submit to Agilent Seller a written plan to correct such noncompliance, which written plan shall be is reasonably acceptable to AgilentSeller, unless Agilent Seller previously affirmatively concurs in writing, in its sole discretion, that Keysight Purchaser or its Affiliate Subsidiary is not in compliancenoncompliance. If Agilent Seller or Keysight Purchaser becomes aware that an Authorized Dealer is not complying with any the Seller Trademark Usage Guidelines, Keysight (but not Agilent) Purchaser shall promptly notify such Authorized Dealer in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Such Authorized Dealer shall then have the Guideline Initial Cure Period to correct such noncompliance or submit to Keysight Purchaser a written plan to correct such noncompliance, which written plan shall be is reasonably acceptable to Keysight Purchaser and AgilentSeller.

Initial Cure Period. If Agilent becomes aware that Keysight BUYER or any of its Affiliates BUYER Subsidiary is not complying with any Trademark Usage Guidelines, Agilent shall notify Keysight BUYER in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Keysight BUYER shall then have forty-five ten (4510) calendar days after receipt of such notice (“Guideline Initial Cure Period”) to correct such noncompliance or submit to Agilent a written plan to correct such noncompliance, which written plan shall be reasonably acceptable to Agilent, unless Agilent previously affirmatively concurs in writing, in its sole discretion, that Keysight BUYER or its Affiliate Subsidiary is in compliance. If Agilent or Keysight BUYER becomes aware that an Authorized Dealer is not complying with any Trademark Usage Guidelines, Keysight BUYER (but not Agilent) shall promptly notify such Authorized Dealer in writing, setting forth in reasonable detail a written description of the noncompliance and any requested action for curing such noncompliance. Such Authorized Dealer shall then have the Guideline Initial Cure Period to correct such noncompliance or submit to Keysight BUYER a written plan to correct such noncompliance, which written plan shall be reasonably acceptable to Keysight BUYER and Agilent.